Memantine for autism spectrum disorder.

Brignell A, Marraffa C, Williams K, May T

Open source

DOI
10.1002/14651858.cd013845.pub2
Published
2022 Aug 25
Container
The Cochrane database of systematic reviews
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/14651858.cd013845.pub2,
  title = {Memantine for autism spectrum disorder.},
  author = {Brignell A and Marraffa C and Williams K and May T},
  year = {2022},
  journal = {The Cochrane database of systematic reviews},
  doi = {10.1002/14651858.cd013845.pub2},
  url = {https://doi.org/10.1002/14651858.cd013845.pub2}
}

RIS

TY  - JOUR
TI  - Memantine for autism spectrum disorder.
AU  - Brignell A
AU  - Marraffa C
AU  - Williams K
AU  - May T
PY  - 2022
JO  - The Cochrane database of systematic reviews
DO  - 10.1002/14651858.cd013845.pub2
UR  - https://doi.org/10.1002/14651858.cd013845.pub2
ER  - 

APA

A, B., C, M., K, W., & T, M. (2022). Memantine for autism spectrum disorder.. The Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd013845.pub2

Source records